Patent directory · USPTO A61K / A61P
Patents matching “t-cell”
88 pharma patents match "t-cell" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 88 pharmaceutical patents matching "t-cell" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9057054
Antigen-specific long-term memory T-cells
granted -
US 8895018
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
granted -
US 8779095
LAT adapter molecule for enhanced T-cell signaling and method of use
granted -
US 8685404
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
granted -
US 8663968
Simian T-cell lymphotropic virus
granted -
US 8664251
Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
granted -
US 7998926
Dimerized T-cell receptor fragment, its compositions and use
granted -
US 7368106
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
granted -
US 7306804
HIV-specific T-cell induction
granted -
US 7175838
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
granted -
US 7052703
T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof
granted -
US 6660719
Inhibiting T-Cell proliferation
expired -
US 6656915
Inhibiting T-cell proliferation
expired -
US 6656471
HIV-specific T-cell induction
expired -
US 6517839
Methods for inducing interleukin-12 and a type1/Th1 T-cell response
expired -
US 6319496
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
expired